Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions... Show more
Axon Enterprise holds a leading position in the public safety technology sector through its integrated ecosystem of hardware, software, and AI solutions. The company’s core offerings in body-worn cameras, conducted energy devices, and real-time intelligence platforms create high switching costs and recurring revenue streams via subscriptions. Competitive advantages stem from scale in law enforcement deployments, data network effects from its platform, and ongoing innovation in artificial intelligence that addresses administrative burdens and response inefficiencies. Medium-term positioning benefits from expansion beyond traditional law enforcement into corrections and enterprise environments, supported by acquisitions that enhance software capabilities in emergency communications.
The August 5, 2026, release of second-quarter results represents an immediate catalyst, as investors will assess progress against the raised 2026 revenue growth target of 30-32% and any updates on AI bookings momentum. Mid-2026 field trials and general availability for new hardware and AI tools, such as Axon Body Mini and Axon Guardian, could drive incremental adoption and bookings. Regulatory decisions around AI use in public safety and data privacy may shape enterprise rollout timelines. Capital allocation priorities, including free cash flow conversion targets of approximately $450 million for the year, could influence sentiment if execution remains strong. Analyst rating revisions and price-target updates from consensus providers will also serve as sentiment indicators, with recent commentary highlighting sustained optimism around the company’s growth trajectory.
The broader public safety technology industry continues to benefit from structural demand for efficiency tools amid persistent staffing shortages and rising call volumes. AI adoption trends are accelerating as agencies seek productivity gains in transcription, redaction, and real-time analytics. Macroeconomic factors such as interest rates directly affect municipal and state budgets that fund technology purchases, while inflation may pressure operating costs. Geopolitical events, including major international gatherings in 2026, could highlight demand for rapid-deployment solutions. Regulatory climate around data privacy and surveillance technology remains a key variable that could either accelerate or constrain adoption depending on policy developments.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. Trend Prediction Engine
Looking to 2026 and beyond, Axon Enterprise’s trajectory centers on continued execution of its AI Era Plan and the integration of acquired platforms into the Axon 911 initiative. Market expansion opportunities in enterprise and corrections segments, alongside technology transitions toward more advanced AI features, support the company’s long-term revenue target of approximately $6 billion by 2028 at a 28% adjusted EBITDA margin. Margin sustainability will depend on operating leverage and product mix as scale increases. Capital allocation priorities emphasize free cash flow generation and reinvestment in innovation. Consensus analyst expectations reflect a constructive view on these structural drivers, with attention on whether growth remains above historical averages amid evolving competitive and regulatory dynamics.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a clinical-stage biopharmaceutical company
Industry AerospaceDefense
A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.
| Ticker / NAME | Correlation To AXON | 1D Price Change % | ||
|---|---|---|---|---|
| AXON | 100% | +5.44% | ||
| TECH - AXON | 61% Loosely correlated | -0.07% | ||
| VCYT - AXON | 58% Loosely correlated | +3.48% | ||
| BEAM - AXON | 57% Loosely correlated | +9.42% | ||
| SEER - AXON | 56% Loosely correlated | -1.34% | ||
| ADPT - AXON | 56% Loosely correlated | +6.23% | ||
More | ||||
The Moving Average Convergence Divergence (MACD) for AXON turned positive on August 04, 2026. Looking at past instances where AXON's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on AXON as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in of 371 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 260 cases where AXON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AXON broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.850) is normal, around the industry mean (10.705). AXON has a moderately high P/E Ratio (244.839) as compared to the industry average of (64.198). Projected Growth (PEG Ratio) (4.801) is also within normal values, averaging (8.304). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (16.807) is also within normal values, averaging (36.455).